Literature DB >> 24195049

Assessment of the anterior chamber parameters after laser iridotomy in primary angle close suspect using Pentacam and gonioscopy.

Alireza Esmaeili1, Behzad Barazandeh, Sina Ahmadi, Alireza Haghi, Seyed Mahdi Ahmadi Hosseini, Fereshteh Abolbashari.   

Abstract

AIM: To evaluate the changes in the anterior segment parameters of the subjects with primary angle closure suspect (PACS) before and after laser iridotomy (LI) using the Pentacam and gonioscopy.
METHODS: Forty-eight eyes of 48 PACS were included. Anterior chamber angle (ACA), central anterior chamber depth (ACD), anterior chamber volume (ACV) and central corneal thickness (CCT) were recorded from the Pentacam before and one month after LI. ACA was graded according to Shaffer classification using the Goldmann gonioscopy.
RESULTS: ACA increased significantly from 25.59±4.41 to 26.46±4.33 degrees (P=0.009) and ACV changed from 85.97±16.07mm(3) to 99.25±15.83mm(3) (P=0.000). The changes in ACD, CCT and intraocular pressure were non-significant (P>0.05). Gonioscopy showed significant widening of the Shaffer angle in 4 quadrants (P<0.001).
CONCLUSION: Pentacam can serve as the objective instrument in assessing the efficacy of LI.

Entities:  

Keywords:  Pentacam; angle closure; glaucoma; gonioscopy; laser iridotomy

Year:  2013        PMID: 24195049      PMCID: PMC3808921          DOI: 10.3980/j.issn.2222-3959.2013.05.25

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  28 in total

1.  Validity and repeatability of anterior chamber depth measurements with Pentacam and Orbscan.

Authors:  Birgit Lackner; Gerald Schmidinger; Christian Skorpik
Journal:  Optom Vis Sci       Date:  2005-09       Impact factor: 1.973

2.  Anterior segment biometry with the Pentacam: comprehensive assessment of repeatability of automated measurements.

Authors:  Hema Shankar; Deepa Taranath; Chandramalar T Santhirathelagan; Konrad Pesudovs
Journal:  J Cataract Refract Surg       Date:  2008-01       Impact factor: 3.351

3.  The effect of iridotomy on iris contour.

Authors:  J C Jin; D R Anderson
Journal:  Am J Ophthalmol       Date:  1990-09-15       Impact factor: 5.258

4.  Persistent symptoms after peripheral iridectomy for angle-closure glaucoma.

Authors:  R F Lowe
Journal:  Aust N Z J Ophthalmol       Date:  1987-02

5.  Argon laser iridotomy in the treatment of patients with primary angle-closure or pupillary block glaucoma: a clinicopathologic study.

Authors:  L W Schwartz; M M Rodrigues; G L Spaeth; B Streeten; C Douglas
Journal:  Ophthalmology       Date:  1978-03       Impact factor: 12.079

Review 6.  Angle closure glaucoma: a mechanistic review.

Authors:  Monisha E Nongpiur; Judy Y F Ku; Tin Aung
Journal:  Curr Opin Ophthalmol       Date:  2011-03       Impact factor: 3.761

7.  Outcome of laser peripheral iridotomy in chronic primary angle closure glaucoma.

Authors:  R Thomas; T Arun; J Muliyil; R George
Journal:  Ophthalmic Surg Lasers       Date:  1999 Jul-Aug

8.  Laser peripheral iridotomy in primary angle-closure suspects: biometric and gonioscopic outcomes: the Liwan Eye Study.

Authors:  Mingguang He; David S Friedman; Jian Ge; Wenyong Huang; Chenjin Jin; Pak Sang Lee; Peng T Khaw; Paul J Foster
Journal:  Ophthalmology       Date:  2006-11-21       Impact factor: 12.079

9.  Ultrasonographic biomicroscopy, Scheimpflug photography, and novel provocative tests in contralateral eyes of Chinese patients initially seen with acute angle closure.

Authors:  David S Friedman; Gus Gazzard; Paul Foster; Joe Devereux; Aimee Broman; Harry Quigley; James Tielsch; Steve Seah
Journal:  Arch Ophthalmol       Date:  2003-05

10.  Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment.

Authors:  Giorgio Marchini; Silvia Babighian; Roberto Tosi; Sergio Perfetti; Luciano Bonomi
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-01       Impact factor: 4.799

View more
  8 in total

1.  Nd: Yag laser iridotomy in Shaffer-Etienne grade 1 and 2: angle widening in our case studies.

Authors:  Sandra Cinzia Carlesimo; Luigi Di Santo; Pietro Bruni; Aloisa Librando; Antonietta Pompea Falace; Andrea Barbato
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

2.  Pentacam could be a useful tool for evaluating and qualifying the anterior chamber morphology.

Authors:  Xiaoyu Li; Zheng Wang; Qun Cao; Lei Hu; Fang Tian; Hong Dai
Journal:  Int J Clin Exp Med       Date:  2014-07-15

Review 3.  Old and new in exploring the anterior chamber angle.

Authors:  Moisescu Raluca; Filip Mircea; Filip Andrei; Dragne Carmen; Nicolae Miruna; Triantafyllidis Grigorios; Ungureanu Ileana
Journal:  Rom J Ophthalmol       Date:  2015 Oct-Dec

4.  Pentacam changes in primary angle-closure glaucoma after different lines of treatment.

Authors:  Tharwat H Mokbel; Abd-Elmonem Elhesy; Ahmed Alnagdy; Mohammed F Elashri; Ahmed M Eissa; Walid M Gaafar; Sherein M Hagras
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

5.  Changes in ocular biometry and anterior chamber parameters after pharmacologic mydriasis and peripheral iridotomy in primary angle closure suspects.

Authors:  Mohammad Reza Razeghinejad; Hamid Lashkarizadeh; Mohammad Hossein Nowroozzadeh; Mohammad Yazdanmehr
Journal:  J Optom       Date:  2016-02-28

6.  Anterior Chamber Changes After Implantable Collamer Lens Implantation in High Myopia Using Pentacam: A Prospective Study.

Authors:  Mohamed Nagy Elmohamady; Walid Abdelghaffar
Journal:  Ophthalmol Ther       Date:  2017-09-20

7.  Comparison of Intraocular Pressure and Anterior Chamber Angle Changes between Pilocarpine and Laser Peripheral Iridotomy.

Authors:  Ardiella Yunard; Virna D Oktariana; Widya Artini; Joedo Prihartono
Journal:  J Curr Glaucoma Pract       Date:  2019 Jan-Apr

Review 8.  Water-drinking Test and Pharmacologic Mydriasis as Provocative Tests in Primary Angle Closure Suspects.

Authors:  Reza Razeghinejad; M Hossein Nowroozzadeh
Journal:  J Ophthalmic Vis Res       Date:  2019-07-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.